Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 12, 2008, Pages 1633-1641

  Shen, Qi ^a,b   Li, Wenji ^a   Lin, Yulian ^a   Katsumi, Hidemasa ^a   Okada, Naoki ^c   Sakane, Toshiyasu ^a   Fujita, Takuya ^d   Yamamoto, Akira ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c OSAKA UNIVERSITY   (Japan)

^d RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; LUCIFER YELLOW; MACROGOL 20000; METHYLPREDNISOLONE; PREDNISOLONE; QUINIDINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MIXTURE; DRUG TRANSPORT; ELECTRIC RESISTANCE; INTESTINE ABSORPTION; JEJUNUM; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT;

EID: 56849107837     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.12.0009     Document Type: Article

References (44)

1. Anderle, P., Niederer, E., Rubas, W., Hilgendorf, C., Spahn-Langguth, H., Wunderli-Allenspach, H., Merkle, H. P., Langguth, P. (1998) P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87: 757-762
2. Arima, H., Yunomae, K., Hirayama, F., Uekama, K. (2001) Contribution of P-glycoprotein to the enhancing effects of dimethyl-β-cyclodextrin on oral bioavailability of tacrolimus. J. Pharmacol. Exp. Ther. 297: 547-555
3. Basit, A. W., Podczeck, F., Newton, J. M., Waddington, W. A., Eli, P. J., Lacey, L. F. (2002) Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine. Pharm. Res. 19: 1368-1374
4. Bogman, K., Zysset, Y., Degen, L., Hopfgartner, G., Gutmann, H., Alsenz, J., Drewe, J. (2005) P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin. Pharmacol. Ther. 7: 24-32
5. Collect, A., Huggs, N. B., Sims, E., Rowland, M., Warhurst, G. (1999) Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. J. Pharmacol. Exp. Ther. 288: 178-188
6. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., Houin, G. (2004) Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 278: 119-131
7. Eagling, V. A., Profit, L., Back, D. J. (1999) Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 48: 543-552
8. Emi, Y., Tsunashima, D., Ogawara, K., Higaki, K., Kimura, T. (1998) Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J. Pharm. Sci. 87: 295-299
9. Faassen, F., Vogel, G., Spanings, H., Vromans, H. (2003) Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int. J. Pharm. 263: 113-122
10. 1,7]-eel calcitonin in rats. J. Control. Release 106: 287-297
11. Gao, Y., He, L., Katsumi, H., Sakane, T., Fujita, T., Yamamoto, A. (2008a) Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Int. J. Pharm. 354: 126-134
12. Gao, Y., He, L., Katsumi, H., Sakane, T., Yamamoto, A. (2008b) Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Int. J. Pharm. 359: 70-78
13. Grass, G. M., Sweetana, S. A. (1988) In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharm. Res. 5: 372-376
14. Hugger, E. D., Audus, K. L., Borchardt, R. T. (2002a) Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J. Pharm. Sci. 91: 1980-1990
15. Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., Borchardt, R. T. (2002b) A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 91: 1991-2002
16. Hugger, E. D., Cole, C. J., Raub, T. J., Burton, P. S., Borchardt, R. T. (2003) Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro. J. Pharm. Sci. 92: 21-26
17. Hunter, J., Hirst, B. H. (1997) Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv. Drug Deliv. Rev. 25: 129-157
18. Johnson, B. M., Charman, W. N., Porter, C. J. (2002) An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS PharmSci. 4: 1-13
19. Lennernas, H. (2003) Intestinal drug absorption and bioavailability: beyond involvement of single transport function. J Pharm. Pharmacol. 55: 429-433
20. Liang, E., Chessic, K., Yazdanian, M. (2000) Evaluation of an accelerated Caco-2 cell permeability model. J. Pharm. Sci. 89: 336-345
21. Lin, Y., Shen, Q., Katsumi, H., Okada, N., Fujita, T., Jiang, X., Yamamoto, A. (2007) Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. Biol. Pharm. Bull. 30: 1301-1307
22. Lo, Y. L., Huang, J. D. (2000) Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol. 59: 665-672
23. Nerurkar, M. M., Burton, P. S., Borchardt, R. T. (1996) The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 13: 528-534
24. Nerurkar, M. M., Ho. N. F., Burton, P. S., Vidmar, T. J., Borchardt, R. T. (1997) Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. J. Pharm. Sci. 86: 813-821
25. Oka, A., Oda, M., Saitoh, H., Nakayama, A., Takada, M., Aungst, B. J. (2002) Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. Biol. Pharm. Bull. 25: 393-396
26. Rege, B. D., Kao, J. P., Polli, J. P. (2002) Effects of nonionic Surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16: 237-246
27. Saitoh, H., Aungst, B. J. (1995) Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 12: 1304-1310
28. Schasteen, C.S., Donovan, M. G., Cogburn, J. N. (1992) A novel in vitro screen to discover agents which increase the absorption of molecules across the intestinal epithelium. J. Control. Release 21: 49-62
29. Shen, Q., Lin, Y., Handa, T., Doi, M., Sugie, M., Wakayama, K., Okada, N., Fujita, T., Yamamoto, A. (2006) Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int. J. Pharm. 313: 49-56
30. Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., Yamamoto, A. (2004) Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J. Pharm. Sci. 93: 877-885
31. Toyobuku, H., Tamai, I., Ueno, K., Tsuji, A. (2003) Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. J. Pharm. Sci. 92: 2249-2259
32. Tozaki, H., Odoriba, T., Iseki, T., Taniguchi, T., Fujita, T., Murakami, M., Muranishi, S., Yamamoto, A. (1998) Use of protease inhibitors to improve calcitonin absorption from the small and large intestine in rats. J. Pharm. Pharmacol. 50: 913-920
33. Troutman, M. D., Thakker, D. R. (2003a) Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm. Res. 20: 1200-1209
34. Troutman, M. D., Thakker, D. R. (2003b) Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells. Pharm. Res. 20: 1192-1199
35. Tsuji, A., Tamai, I., Sakata, A., Tenda, Y., Terasaki, T. (1993) Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46: 1096-1099
36. Uchiyama, T., Yamamoto, A., Hatano, H., Fujita, T., Muranishi, S. (1996) Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. Biol. Pharm. Bull. 19: 1618-1621
37. Uchiyama, T., Sugiyama, T., Quan, Y. S., Kotani, A., Okada, N., Fujita, T., Muranishi, S., Yamamoto, A. (1999) Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption enhancing mechanism of n-lauryl-β- D-maltopyranoside. J. Pharm. Pharmacol. 51: 1241-1250
38. Wacher, V. J., Silverman, J. A., Zhang, Y., Benet, L. Z. (1998) Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. J. Pharm. Sci. 87: 1322-1330
39. Wacher, V. J., Salphati, L., Benet, L. Z. (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev. 46: 89-102
40. Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., Muranishi, S. (1994) Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11: 1496-1500
41. Yamamoto, A., Uchiyama, T., Nishikawa, R., Fujita, T., Muranishi, S. (1996) Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effect of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J. Pharm. Pharmacol. 48: 1285-1289
42. Yamamoto, A., Tatsumi, H., Maruyama, M., Uchiyama, T., Okada, N., Fujita, T. (2001) Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J. Pharmacol. Exp. Ther. 296: 84-90
43. Zhang, H., Yao, M., Morrison, R. A., Chong, S. (2003) Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch. Pharm. Res. 26: 768-772
44. Zhang, L., Zheng, Y., Chow, M. S., Zuo, Z. (2004) Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287: 1-12